Varex Imaging's Q1 revenue up 5%, slightly beats estimates

Reuters
Feb 11
<a href="https://laohu8.com/S/VREX">Varex Imaging</a>'s Q1 revenue up 5%, slightly beats estimates

Overview

  • X-ray imaging components maker's Q1 revenue rose 5% yr/yr, slightly beating analysts' expectations

  • Non-GAAP EPS increased to $0.19 from $0.10 in the prior year

  • Growth driven by 17% increase in Industrial segment revenue, led by cargo systems

Outlook

  • Company expects Q2 FY26 revenue between $210 mln and $225 mln

  • Varex anticipates strong demand for CT products and cargo security systems

  • Company forecasts Q2 FY26 non-GAAP EPS between $0.15 and $0.25

Result Drivers

  • CARGO SYSTEMS - Growth in the quarter was driven by strength in cargo systems business, contributing to a 17% year-over-year increase in Industrial segment revenue, said CEO Sunny Sanyal

  • INVENTORY IMPACT - Cash outflow from operations was driven by an increase in working capital, primarily due to inventory

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Slight Beat*

$209.60 mln

$207.69 mln (5 Analysts)

Q1 Net Income

$2.40 mln

Q1 Gross Margin

33.00%

Q1 Adjusted Operating Margin

9.00%

Q1 Operating Income

$15.40 mln

Q1 Pretax Profit

$3.80 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

  • Wall Street's median 12-month price target for Varex Imaging Corp is $18.00, about 28.2% above its February 9 closing price of $14.04

  • The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release: ID:nBwbC47Lfa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10